|
GB0305929D0
(en)
*
|
2003-03-14 |
2003-04-23 |
Novartis Ag |
Organic compounds
|
|
US7521457B2
(en)
*
|
2004-08-20 |
2009-04-21 |
Boehringer Ingelheim International Gmbh |
Pyrimidines as PLK inhibitors
|
|
US8119655B2
(en)
|
2005-10-07 |
2012-02-21 |
Takeda Pharmaceutical Company Limited |
Kinase inhibitors
|
|
TW200804364A
(en)
|
2006-02-22 |
2008-01-16 |
Boehringer Ingelheim Int |
New compounds
|
|
CA2648170A1
(en)
*
|
2006-04-10 |
2007-10-18 |
Boehringer Ingelheim International Gmbh |
2, 4-diaminopyrimidine derivatives and their use for the treatment of cancer
|
|
PE20120006A1
(es)
*
|
2006-05-15 |
2012-02-02 |
Boehringer Ingelheim Int |
Compuestos derivados de pirimidina como inhibidores de la quinasa aurora
|
|
DE102006039003A1
(de)
|
2006-08-19 |
2008-02-21 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Neue Verbindungen
|
|
SG158147A1
(en)
*
|
2006-10-09 |
2010-01-29 |
Takeda Pharmaceutical |
Kinase inhibitors
|
|
EP2223925A1
(en)
*
|
2006-10-09 |
2010-09-01 |
Takeda Pharmaceutical Company Limited |
Kinase inhibitors
|
|
ES2555803T3
(es)
|
2006-10-23 |
2016-01-08 |
Cephalon, Inc. |
Fusión de derivados bicíclicos 2,4-diaminopirimidina como utilizar inhibidores ALK y c-Met
|
|
DE102007010801A1
(de)
|
2007-03-02 |
2008-09-04 |
Bayer Cropscience Ag |
Diaminopyrimidine als Fungizide
|
|
CN101678215B
(zh)
*
|
2007-04-18 |
2014-10-01 |
辉瑞产品公司 |
用于治疗异常细胞生长的磺酰胺衍生物
|
|
CN101679396B
(zh)
*
|
2007-05-16 |
2012-06-06 |
伊莱利利公司 |
三唑基氨基嘧啶化合物
|
|
US9409886B2
(en)
|
2007-07-05 |
2016-08-09 |
Array Biopharma Inc. |
Pyrimidyl cyclopentanes as AKT protein kinase inhibitors
|
|
WO2009006567A2
(en)
|
2007-07-05 |
2009-01-08 |
Array Biopharma Inc. |
Pyrimidyl cyclopentanes as akt protein kinase inhibitors
|
|
EA201000101A1
(ru)
*
|
2007-07-16 |
2010-08-30 |
Астразенека Аб |
Производные пиримидина 934
|
|
EP2188269B1
(de)
|
2007-08-14 |
2014-05-07 |
Boehringer Ingelheim International GmbH |
Arylsulfonamide mit analgetischer wirkung
|
|
EP2025675A1
(de)
|
2007-08-14 |
2009-02-18 |
Boehringer Ingelheim International GmbH |
Arylsulfonamide mit analgetischer Wirkung
|
|
US8278313B2
(en)
|
2008-03-11 |
2012-10-02 |
Abbott Laboratories |
Macrocyclic spiro pyrimidine derivatives
|
|
EP2100894A1
(en)
|
2008-03-12 |
2009-09-16 |
4Sc Ag |
Pyridopyrimidines used as Plk1 (polo-like kinase) inhibitors
|
|
US8436005B2
(en)
|
2008-04-03 |
2013-05-07 |
Abbott Laboratories |
Macrocyclic pyrimidine derivatives
|
|
US9273077B2
(en)
|
2008-05-21 |
2016-03-01 |
Ariad Pharmaceuticals, Inc. |
Phosphorus derivatives as kinase inhibitors
|
|
MX353308B
(es)
|
2008-05-21 |
2018-01-08 |
Ariad Pharma Inc |
Derivados fosforosos como inhibidores de cinasa.
|
|
US11351168B1
(en)
|
2008-06-27 |
2022-06-07 |
Celgene Car Llc |
2,4-disubstituted pyrimidines useful as kinase inhibitors
|
|
NZ603525A
(en)
*
|
2008-06-27 |
2015-02-27 |
Celgene Avilomics Res Inc |
Pyrimidine based compound and uses thereof
|
|
US8338439B2
(en)
|
2008-06-27 |
2012-12-25 |
Celgene Avilomics Research, Inc. |
2,4-disubstituted pyrimidines useful as kinase inhibitors
|
|
KR20110053424A
(ko)
*
|
2008-08-12 |
2011-05-23 |
베링거 인겔하임 인터내셔날 게엠베하 |
사이클로알킬-치환된 피페라진 화합물의 제조 방법
|
|
EP2161259A1
(de)
|
2008-09-03 |
2010-03-10 |
Bayer CropScience AG |
4-Halogenalkylsubstituierte Diaminopyrimidine als Fungizide
|
|
TW201024281A
(en)
|
2008-11-24 |
2010-07-01 |
Boehringer Ingelheim Int |
New compounds
|
|
AR074210A1
(es)
*
|
2008-11-24 |
2010-12-29 |
Boehringer Ingelheim Int |
Derivados de pirimidina como inhibidores de ptk2-quinasa
|
|
EP2196465A1
(en)
|
2008-12-15 |
2010-06-16 |
Almirall, S.A. |
(3-oxo)pyridazin-4-ylurea derivatives as PDE4 inhibitors
|
|
US8809343B2
(en)
*
|
2008-12-26 |
2014-08-19 |
Fudan University |
Pyrimidine derivative, preparation method and use thereof
|
|
JP5815411B2
(ja)
|
2008-12-30 |
2015-11-17 |
ライジェル ファーマシューティカルズ， インコーポレイテッド |
ピリミジンジアミンキナーゼ阻害剤
|
|
US20110071158A1
(en)
*
|
2009-03-18 |
2011-03-24 |
Boehringer Ingelheim International Gmbh |
New compounds
|
|
WO2010122038A1
(en)
|
2009-04-24 |
2010-10-28 |
F. Hoffmann-La Roche Ag |
Inhibitors of bruton's tyrosine kinase
|
|
US9908884B2
(en)
|
2009-05-05 |
2018-03-06 |
Dana-Farber Cancer Institute, Inc. |
EGFR inhibitors and methods of treating disorders
|
|
BRPI1010974A2
(pt)
*
|
2009-05-22 |
2019-09-24 |
Exelixis Inc |
benzoxazepinas baseada em inibidores p13k/ m tor contra doenças proliferativas
|
|
CN102459248A
(zh)
|
2009-05-26 |
2012-05-16 |
埃克塞里艾克西斯公司 |
作为PI3K/mTOR抑制剂的苯并氧杂环庚三烯以及它们使用与制造方法
|
|
TW201100441A
(en)
|
2009-06-01 |
2011-01-01 |
Osi Pharm Inc |
Amino pyrimidine anticancer compounds
|
|
ES2642586T3
(es)
|
2009-07-27 |
2017-11-16 |
Gilead Sciences, Inc. |
Compuestos heterocíclicos condensados como moduladores de canales iónicos
|
|
US8933227B2
(en)
|
2009-08-14 |
2015-01-13 |
Boehringer Ingelheim International Gmbh |
Selective synthesis of functionalized pyrimidines
|
|
WO2011018517A1
(en)
|
2009-08-14 |
2011-02-17 |
Boehringer Ingelheim International Gmbh |
Regioselective preparation of 2-amino-5-trifluoromethylpyrimidine derivatives
|
|
US9556426B2
(en)
|
2009-09-16 |
2017-01-31 |
Celgene Avilomics Research, Inc. |
Protein kinase conjugates and inhibitors
|
|
JP2013516422A
(ja)
|
2009-12-30 |
2013-05-13 |
アビラ セラピューティクス， インコーポレイテッド |
タンパク質のリガンド−指向性共有的修飾
|
|
US8927547B2
(en)
|
2010-05-21 |
2015-01-06 |
Noviga Research Ab |
Pyrimidine derivatives
|
|
ES2577829T3
(es)
|
2010-06-04 |
2016-07-19 |
F. Hoffmann-La Roche Ag |
Derivados de aminopirimidina como moduladores de la LRRK2
|
|
EP2588197B1
(en)
|
2010-07-02 |
2014-11-05 |
Gilead Sciences, Inc. |
Fused heterocyclic compounds as ion channel modulators
|
|
MX336875B
(es)
|
2010-08-10 |
2016-02-04 |
Celgene Avilomics Res Inc |
Sal de besilato de un inhibidor de tirosina cinasa de bruton (btk).
|
|
EP2635284B1
(en)
|
2010-11-01 |
2019-12-18 |
Celgene CAR LLC |
Heterocyclic compounds and uses thereof
|
|
WO2012061303A1
(en)
|
2010-11-01 |
2012-05-10 |
Avila Therapeutics, Inc. |
Heteroaryl compounds and uses thereof
|
|
NO2638031T3
(https=)
|
2010-11-10 |
2018-03-10 |
|
|
|
WO2012064706A1
(en)
|
2010-11-10 |
2012-05-18 |
Avila Therapeutics, Inc. |
Mutant-selective egfr inhibitors and uses thereof
|
|
EP2646448B1
(en)
|
2010-11-29 |
2017-08-30 |
OSI Pharmaceuticals, LLC |
Macrocyclic kinase inhibitors
|
|
US8546443B2
(en)
|
2010-12-21 |
2013-10-01 |
Boehringer Ingelheim International Gmbh |
Benzylic oxindole pyrimidines
|
|
DK2688883T3
(en)
|
2011-03-24 |
2016-09-05 |
Noviga Res Ab |
pyrimidine
|
|
EP2704572B1
(en)
|
2011-05-04 |
2015-12-30 |
Ariad Pharmaceuticals, Inc. |
Compounds for inhibiting cell proliferation in egfr-driven cancers
|
|
KR20140033377A
(ko)
|
2011-05-10 |
2014-03-18 |
길리애드 사이언시즈, 인코포레이티드 |
나트륨 채널 조절제로서의 융합된 헤테로시클릭 화합물
|
|
NO3175985T3
(https=)
|
2011-07-01 |
2018-04-28 |
|
|
|
UY34171A
(es)
|
2011-07-01 |
2013-01-31 |
Gilead Sciences Inc |
Compuestos heterocíclicos fusionados como moduladores del canal iónico
|
|
US9364476B2
(en)
|
2011-10-28 |
2016-06-14 |
Celgene Avilomics Research, Inc. |
Methods of treating a Bruton's Tyrosine Kinase disease or disorder
|
|
ES2575604T3
(es)
|
2012-01-13 |
2016-06-29 |
Bristol-Myers Squibb Company |
Compuestos de piridilo sustituidos con tiazolilo o tiadiazolilo útiles como inhibidores cinasa
|
|
EP2802576B1
(en)
|
2012-01-13 |
2018-06-27 |
Bristol-Myers Squibb Company |
Heterocyclic-substituted pyridyl compounds useful as kinase inhibitors
|
|
CN104169275B
(zh)
|
2012-01-13 |
2017-06-09 |
百时美施贵宝公司 |
用作激酶抑制剂的三唑取代的吡啶化合物
|
|
BR112014022790B1
(pt)
|
2012-03-15 |
2022-04-19 |
Celgene Car Llc |
Sais de um inibidor de quinase de receptor de fator do crescimento epidermal, composição farmacêutica e usos do mesmo
|
|
CA2866852C
(en)
|
2012-03-15 |
2020-12-29 |
Celgene Avilomics Research, Inc. |
Solid forms of an epidermal growth factor receptor kinase inhibitor
|
|
WO2013169401A1
(en)
|
2012-05-05 |
2013-11-14 |
Ariad Pharmaceuticals, Inc. |
Compounds for inhibiting cell proliferation in egfr-driven cancers
|
|
WO2014060375A2
(en)
*
|
2012-10-18 |
2014-04-24 |
Bayer Pharma Aktiengesellschaft |
5-fluoro-n-(pyridin-2-yl)pyridin-2-amine derivatives containing a sulfone group
|
|
BR112015009850A2
(pt)
|
2012-11-08 |
2017-07-11 |
Bristol Myers Squibb Co |
compostos de piridila substituídos por heteroarila úteis como moduladores de quinase
|
|
JP6215338B2
(ja)
|
2012-11-08 |
2017-10-18 |
ブリストル−マイヤーズ スクイブ カンパニーＢｒｉｓｔｏｌ−Ｍｙｅｒｓ Ｓｑｕｉｂｂ Ｃｏｍｐａｎｙ |
キナーゼモジュレーターとして有用な二環式ヘテロ環置換ピリジル化合物
|
|
US9126950B2
(en)
|
2012-12-21 |
2015-09-08 |
Celgene Avilomics Research, Inc. |
Heteroaryl compounds and uses thereof
|
|
MX2015009952A
(es)
|
2013-02-08 |
2015-10-05 |
Celgene Avilomics Res Inc |
Inhibidores de cinasas reguladas por señales extracelulares (erk) y sus usos.
|
|
JP6091248B2
(ja)
*
|
2013-02-22 |
2017-03-08 |
キヤノン株式会社 |
プリンタ
|
|
JP6387360B2
(ja)
|
2013-03-14 |
2018-09-05 |
ノバルティス アーゲー |
変異ｉｄｈの阻害薬としての３−ピリミジン−４−イル−オキサゾリジン−２−オン
|
|
US9611283B1
(en)
|
2013-04-10 |
2017-04-04 |
Ariad Pharmaceuticals, Inc. |
Methods for inhibiting cell proliferation in ALK-driven cancers
|
|
US9492471B2
(en)
|
2013-08-27 |
2016-11-15 |
Celgene Avilomics Research, Inc. |
Methods of treating a disease or disorder associated with Bruton'S Tyrosine Kinase
|
|
US9415049B2
(en)
|
2013-12-20 |
2016-08-16 |
Celgene Avilomics Research, Inc. |
Heteroaryl compounds and uses thereof
|
|
UY35935A
(es)
|
2014-01-03 |
2015-06-30 |
Bristol Myers Squibb Company Una Corporación Del Estado De Delaware |
Compuestos de nicotinamida sustituida con heteroarilo como inhibidores de quinasa y moduladores de irak-4
|
|
EP3179858B1
(en)
|
2014-08-13 |
2019-05-15 |
Celgene Car Llc |
Forms and compositions of an erk inhibitor
|
|
ES2822956T3
(es)
|
2015-06-24 |
2021-05-05 |
Bristol Myers Squibb Co |
Compuestos de aminopiridina sustituidos con heteroarilo
|
|
EP3313840B1
(en)
|
2015-06-24 |
2019-07-24 |
Bristol-Myers Squibb Company |
Heteroaryl substituted aminopyridine compounds
|
|
US10618903B2
(en)
|
2015-06-24 |
2020-04-14 |
Bristol-Myers Squibb Company |
Heteroaryl substituted aminopyridine compounds
|
|
ES2760625T3
(es)
|
2015-07-29 |
2020-05-14 |
Esteve Pharmaceuticals Sa |
Derivados de N-(2-(3-(bencil(metil)amino)pirrolidin-1-il)etil)-N-fenil)propionamida y compuestos relacionados como ligandos duales de receptores sigma 1 y opioide mu y para el tratamiento del dolor
|
|
TWI724056B
(zh)
*
|
2015-11-19 |
2021-04-11 |
美商卡默森屈有限公司 |
Ｃｘｃｒ２抑制劑
|
|
TWI734715B
(zh)
|
2015-11-19 |
2021-08-01 |
美商卡默森屈有限公司 |
趨化因子受體調節劑
|
|
CN106831730B
(zh)
*
|
2017-01-11 |
2019-11-26 |
温州医科大学 |
一种取代的二氨基嘧啶类化合物及其在制备抗恶性肿瘤药物中的用途
|
|
PT3621960T
(pt)
|
2017-05-11 |
2021-09-16 |
Bristol Myers Squibb Co |
Tienopiridinas e benzotiofenos úteis como inibidores de irak4
|
|
EP3737366B1
(en)
|
2018-01-08 |
2026-02-25 |
ChemoCentryx, Inc. |
Methods of treating generalized pustular psoriasis with an antagonist of ccr6 or cxcr2
|
|
EP3999508B1
(en)
|
2019-07-18 |
2023-08-30 |
Bristol-Myers Squibb Company |
Tricyclic heteroaryl compounds useful as irak4 inhibitors
|
|
WO2021011727A1
(en)
|
2019-07-18 |
2021-01-21 |
Bristol-Myers Squibb Company |
PYRAZOLO[3,4-d]PYRROLO[1,2-b]PYRIDAZINYL COMPOUNDS USEFUL AS IRAK4 INHIBITORS
|
|
WO2021026181A1
(en)
|
2019-08-06 |
2021-02-11 |
Bristol-Myers Squibb Company |
Bicyclic heterocyclic compounds useful as irak4 inhibitors
|
|
ES3059914T3
(en)
|
2019-08-13 |
2026-03-24 |
Bristol Myers Squibb Co |
Bicyclic heteroaryl compounds useful as irak4 inhibitors
|
|
WO2021113689A1
(en)
*
|
2019-12-06 |
2021-06-10 |
Yale University |
Spak/osr inhibitors and methods of using same
|
|
WO2021158495A1
(en)
|
2020-02-03 |
2021-08-12 |
Bristol-Myers Squibb Company |
Benzo[5,6][1,4]dioxino[2,3-b]pyridine compounds useful as irak4 inhibitors
|
|
US12421230B2
(en)
|
2020-02-03 |
2025-09-23 |
Bristol-Myers Squibb Company |
Tricyclic heteroaryl compounds useful as IRAK4 inhibitors
|
|
WO2022147622A1
(en)
*
|
2021-01-07 |
2022-07-14 |
Ontario Institute For Cancer Research (Oicr) |
Isoindolinone aminopyrimidine compounds as inhibitors of nuak kinases, compositions and uses thereof
|
|
CA3252402A1
(en)
*
|
2022-02-28 |
2025-07-07 |
Wigen Biomedicine Technology (shanghai) Co., Ltd. |
COMPOUND USED AS A FAK INHIBITOR AND ITS USE
|
|
WO2024051717A1
(zh)
*
|
2022-09-08 |
2024-03-14 |
上海深势唯思科技有限责任公司 |
作为plk1抑制剂的化合物及其制备方法和用途
|
|
CN119285624B
(zh)
*
|
2024-09-25 |
2025-09-23 |
南方医科大学中西医结合医院 |
一种含噻吩的嘧啶类化合物及其制备方法与在制备具有抗癌作用的药物中的应用
|